Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Transdermal Versus Oral Oxybutynin in Pediatric OAB [NA]
The study comparing transdermal and oral oxybutynin in pediatric overactive bladder has completed; no results are provided in the snippet.
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Home-Based Transcutaneous Remotely Monitored Posterior Tibial Neuromodulation [NA]
A study evaluating home-based, remotely monitored transcutaneous posterior tibial nerve stimulation for overactive bladder is currently recr…
-
CLINICAL_TRIALS withdrawal · 2025-07-18Clinical Trial Update: Prophylactic Analgesia for Bladder Botox Injections [Phase 4]
A Phase 4 clinical trial evaluating prophylactic analgesia for bladder Botox injections has been withdrawn.
-
EMA approval · 2025-07-08EMA Authorised: Obgemsa (vibegron) — Pierre Fabre Medicament
EMA has authorised Obgemsa (vibegron) for overactive bladder and urinary incontinence. The marketing authorization holder is Pierre Fabre Me…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Prevalence And Risk Factors of Overactive Bladder Syndrome Among Egyptian Medical Students, and Their Impact On Health-Related Quality Of Life
A completed clinical trial from Zagazig University assessing how common overactive bladder is among Egyptian medical students, identifying r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Treatment of Overactive Bladder With Anticholinergic Agents
A clinical trial status update regarding the treatment of overactive bladder with anticholinergic agents, currently listed as ACTIVE_NOT_REC…
-
FDA approval · 2025-06-30FDA Approved: MIRABEGRON — Original Application (Qilu Pharmaceutical Co., Ltd.)
The FDA approved Qilu Pharmaceutical Co., Ltd.'s generic mirabegron (ANDA 217989) for overactive bladder.
-
FDA approval · 2025-06-17FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for tolterodine tartrate submitted by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Comparing Treatments for Overactive Bladder in Taiwan: A Study of Outcomes [NA]
A Taiwan-based clinical trial is recruiting to compare treatments for overactive bladder.
-
CLINICAL_TRIALS withdrawal · 2025-06-17Clinical Trial Update: Development of Novel Cystometrics for Overactive Bladder
A clinical trial evaluating novel cystometrics for overactive bladder has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Axonics SacRal NeuromodulaTIon System RegisTRY Study
Axonics reports completion of the RegisTRY sacral neuromodulation study with results posted on 2025-06-05, evaluating urinary retention, uri…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Clinical Efficacy Evaluation of Electroacupuncture as Adjuvant Therapy for Female Patients With Overactive Bladder [NA]
The study is evaluating electroacupuncture as adjuvant therapy for female patients with overactive bladder and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in Children [Phase 4]
Phase 4 clinical trial update evaluating safety and efficacy of posterior tibial nerve stimulation for overactive bladder in children; the s…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive Bladder [NA]
A clinical trial comparing electroacupuncture with solifenacin succinate for female overactive bladder is currently recruiting.
-
FDA approval · 2025-05-21FDA Approved: DARIFENACIN — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Darifenacin from Torrent Pharmaceuticals Limited, expanding access to this overactive bladder th…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Cyclic Versus Continuous Sacral Neuromodulation for LUTS [NA]
An update on a trial comparing cyclic versus continuous sacral neuromodulation for lower urinary tract symptoms in Overactive Bladder Syndro…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder [Phase 4]
Phase 4 clinical trial evaluating the efficacy of solifenacin or mirabegron with local estrogen versus combination pharmacotherapy for overa…
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction [NA]
A completed clinical trial evaluating optimized injections of OnabotulinumtoxinA for neurogenic lower urinary tract dysfunction has posted r…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity [Phase 4]
This ClinicalTrials.gov entry describes a Phase 4 trial evaluating a combined pharmacotherapy versus solifenacin with vaginal estrogen cream…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity [Phase 4]
Phase 4 clinical trial evaluating the efficacy of Botox injections versus a combination pharmacotherapy for detrusor overactivity/overactive…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: TEST-ON - Does iStim Reduce Urinary Urgency? [NA]
A completed clinical trial evaluating whether iStim reduces urinary urgency in people with overactive bladder.
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Changes in the Urinary Microbiome and Metabolome During Treatment of the Overactive Bladder in Female Patients
This clinical trial aims to study how the urinary microbiome and metabolome change during treatment of overactive bladder in female patients…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Multiple Sclerosis and Overactive Bladder Treatment [NA]
ClinicalTrials.gov entry indicates completion of a study addressing multiple sclerosis–related neurogenic/overactive bladder.
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection [Phase 4]
Phase 4 clinical trial evaluating methenamine hippurate after intradetrusor onabotulinumtoxinA injections for overactive bladder, with recru…
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women [Phase 4]
Phase 4 trial update examining whether vaginal 17β-estradiol improves urinary storage symptoms in postmenopausal women.